Adrian McKemey's most recent trade in Certara Inc was a trade of 10,849 Common Stock done . Disclosure was reported to the exchange on April 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Certara Inc | Adrian McKemey | President, Drug Dev. Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 10,849 | 10,849 | - | 0 | Common Stock | |
| Certara Inc | Adrian McKemey | President, Drug Dev. Solutions | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 10,849 | 21,698 | - | - | Restricted Stock Units | |
| Certara Inc | Adrian McKemey | President, Drug Dev. Solutions | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.70 per share. | 01 Apr 2026 | 2,642 | 8,207 | - | 5.7 | 15,059 | Common Stock |
| Certara Inc | Adrian McKemey | President, Drug Dev. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 48,820 | 48,820 | - | - | Performance Stock Units | |
| Certara Inc | Adrian McKemey | President, Drug Dev. Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2025 | 32,547 | 32,547 | - | - | Restricted Stock Units |